Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 276.11M P/E - EPS this Y 3.50% Ern Qtrly Grth -
Income -128.91M Forward P/E -3.95 EPS next Y 14.50% 50D Avg Chg -12.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 21.00%
Dividend N/A Price/Book 4.11 EPS next 5Y - 52W High Chg -32.00%
Recommedations 2.00 Quick Ratio 3.47 Shares Outstanding 167.94M 52W Low Chg 168.00%
Insider Own 1.15% ROA -61.03% Shares Float 127.88M Beta 0.35
Inst Own 67.43% ROE -489.12% Shares Shorted/Prior 16.51M/11.92M Price 1.74
Gross Margin - Profit Margin - Avg. Volume 3,643,658 Target Price 4.05
Oper. Margin - Earnings Date Aug 8 Volume 1,671,654 Change 0.00%
About X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase II clinical trial to treat congenital, idiopathic, or cyclic neutropenia. The company is also developing X4P-003, a CXCR4 antagonist for the treatment of CXCR4 dependent disorders and primary immunodeficiencies; and X4P-002, a CXCR4 antagonist for the treatment of blood-brain barrier diseases. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company is headquartered in Boston, Massachusetts.

X4 Pharmaceuticals, Inc. News
07/08/24 XFOR: Positive Interim Data from Ongoing Phase 2 Trial of Mavorixafor in Chronic Neutropenia Patients…
05:30 AM X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) and Initiation of Pivotal Phase 3 CN Trial
06/03/24 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/29/24 X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia
05/13/24 X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
05/09/24 X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
05/08/24 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript
05/08/24 XFOR: Data from Phase 2 CN Trial Expected in June 2024…
05/08/24 X4 Pharmaceuticals Inc (XFOR) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
05/07/24 X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
04/30/24 X4 Pharmaceuticals to Report First-Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 7, 2024
04/30/24 XFOR: XOLREMDI™ Approved by FDA…
04/29/24 UPDATE 1-US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
04/29/24 X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
04/11/24 X4 Pharmaceuticals, Inc.'s (NASDAQ:XFOR) market cap decline of US$42m may not have as much of an impact on institutional owners after a year of 7.0% returns
04/02/24 XFOR: PDUFA Date of April 30, 2024 for Mavorixafor for WHIM Syndrome…
04/01/24 X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences
03/22/24 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript
03/21/24 Q4 2023 X4 Pharmaceuticals Inc Earnings Call
03/21/24 X4 Pharmaceuticals Inc (XFOR) Reports Fourth-Quarter and Full-Year 2023 Financial Results
XFOR Chatroom

User Image BioRich Posted - 2 hours ago

$XFOR didn't make it to .90$ but did move nicely AH to 0.88$. Will be watching this closely next week. Previous predictions still on track.

User Image BioRich Posted - 12 hours ago

$VRNA $TGTX $XFOR $NRSN and $DJT beautiful break into Friday AH's into the weekend. Love it! #LFG #Xaine

User Image BioRich Posted - 12 hours ago

@MarcusEpi How? Not blocking you because I believe everyone is entitled to share your opinion here but would sure like to know why you think this is a scam...$XFOR

User Image BioRich Posted - 12 hours ago

$XFOR Bussin' through .90$ after slight hold at EOD at .879$. This has been tracking EXACTLY as we've predicted. Like and Follow for more tips/suggestions. We'd love to hear yours too! Let's make some money! Cheers! #XaineSplaine

User Image MarcusEpi Posted - 14 hours ago

$XFOR Scam trap

User Image BioRich Posted - 14 hours ago

@RamboTrader_ absolutely. Down 45% on a slight miss? We're taking that every time. Just entered. Wasn't even on my radar but couldn't pass this opportunity up. We've bought the over-exaggerated drops on $XFOR $AGEN $NRSN and $TNXP and have done quite well. Like and Follow for more tips/suggestions. We'd love to hear yours too! Let's make some money! Cheers!

User Image Gunnar1 Posted - 17 hours ago

$BCRX $XFOR $RVNC $LYRA $BYU Hello Croatia!

User Image BiotechPsycho Posted - 20 hours ago

$XFOR surprised this ran up so much. Like 80% from 50s.

User Image h8ster Posted - 1 day ago

$XFOR the 90's will a beast to get through. Should reach $1.00 on the ER run up.

User Image BioRich Posted - 1 day ago

@flyinghollaender Thank you for the suggestions. I really like $XFOR. Not so well versed in $MIST. What causes them to stand out??

User Image flyinghollaender Posted - 1 day ago

@BioRich $MIST $XFOR

User Image BigALB Posted - 1 day ago

$XFOR adding a little more at this top boli on the daily. GLTA

User Image zaher33 Posted - 1 day ago

$XFOR 🚀🚀🚀🚀

User Image heidibio Posted - 1 day ago

$XFOR let’s hear it for the 90s!

User Image Gunnar1 Posted - 1 day ago

$BCRX $XFOR $RVNC $LYRA $BYU Cockta, the socialistic slovenian version of Coke...

User Image BigALB Posted - 1 day ago

$XFOR position filled in full. GLTA

User Image Gunnar1 Posted - 1 day ago

$BCRX $XFOR $RVNC $LYRA $BYU Next stop on our tour to Croatia is Ljubljana. Stay safe and God bless

User Image BigALB Posted - 1 day ago

$XFOR got the last bit on for .88, avg will be .868 then S/L set for .94, let the games begin. GLTA

User Image heidibio Posted - 1 day ago

$XFOR strong 💪

User Image BigALB Posted - 1 day ago

$XFOR looking to fill another chuck at the 50SMA tap today, i think we hit it again and get rejected. GLTA If not im in just under half my usual full position right now just above .862.

User Image MarcusEpi Posted - 1 day ago

$XFOR Pile of shit

User Image BioRich Posted - 2 days ago

$XFOR still see this climbing to 1.20$ in the next month. Throw $NRSN into that mix as well with a Sept. 1 PT of 1.18$ Models show $AGEN to $7.43 and $IOVA to continue its decline settling at around 8.99. Like and Follow for more tips/suggestions Let's make some money. Cheers!

User Image Old_Man_58 Posted - 2 days ago

$XFOR Item 7.01 Regulation FD Disclosure On July 19, 2024, X4 Pharmaceuticals, Inc. (the “Company”) posted an updated corporate presentation on the Company’s website. To access the presentation, investors should visit the “Investors” section of the Company’s website at www.x4pharma.com

User Image MrWaikoloa Posted - 2 days ago

$XFOR BigAl is back. Looks like we’ll see $1 soon.

User Image KiwiTraveller Posted - 2 days ago

$XFOR and $HOOK Have added and still massive fan of both

User Image Toodof1345 Posted - 2 days ago

$XFOR Slowly building up, almost got to 10k shares. Waiting for this really soar in the next few months.

User Image BigALB Posted - 2 days ago

$XFOR Im back in, off the 50 day rejection, and the mid point momo signal rejection. GLTA

User Image nomas Posted - 2 days ago

$AQST and $XFOR holding green today in a sea of red. hopefully can maintain through close

User Image AG_Trader1 Posted - 2 days ago

$XFOR If company is able to update revenue situation with Xolremdi this has a chance to move quickly over $1

User Image markovb343 Posted - 2 days ago

$XFOR back to $1, then watch out the next couple quarters. We could be going for blastoff if WHIM commercialization surprises to the upside.

Analyst Ratings
HC Wainwright & Co. Buy Jun 28, 24
Cantor Fitzgerald Overweight May 31, 24
HC Wainwright & Co. Buy Apr 30, 24
HC Wainwright & Co. Buy Mar 22, 24
B. Riley Securities Neutral Dec 12, 23
HC Wainwright & Co. Buy Aug 11, 23
Stifel Buy May 17, 23
HC Wainwright & Co. Buy May 5, 23
B. Riley Securities Buy Apr 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ragan Paula President and CEO President and CEO Nov 01 Sell 0.82 239,437 196,338 836,441 11/03/23
WYZGA MICHAEL S Director Director Aug 18 Buy 1.195 25,000 29,875 76,667 08/22/23
Stewart Murray Interim Chief Medica.. Interim Chief Medical Officer Aug 09 Sell 1.06 130,056 137,859 146,504 08/11/23
Ragan Paula President and CEO President and CEO May 31 Sell 1.95 6,292 12,269 557,245 05/31/23
Ragan Paula President and CEO President and CEO Jun 03 Sell 1.21 6,292 7,613 661,806 06/06/22